HomeRPRX • NASDAQ
Royalty Pharma plc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 593.64M | -0.41% |
Operating expense | 68.09M | 14.08% |
Net income | 208.21M | -57.88% |
Net profit margin | 35.07 | -57.71% |
Earnings per share | 1.15 | -24.25% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 987.23M | 99.31% |
Total assets | 18.22B | 11.24% |
Total liabilities | 7.88B | 25.13% |
Total equity | 10.34B | — |
Shares outstanding | 433.32M | — |
Price to book | 2.00 | — |
Return on assets | 4.98% | — |
Return on capital | 5.05% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 208.21M | -57.88% |
Cash from operations | 742.53M | -3.90% |
Cash from investing | -505.59M | 49.45% |
Cash from financing | -257.96M | -11.24% |
Net change in cash | -21.03M | 95.42% |
Free cash flow | -239.98M | 60.12% |
Previous close
$31.17
Day range
$30.89 - $31.35
Year range
$24.05 - $34.20
Market cap
17.80B USD
Avg Volume
4.83M
P/E ratio
16.16
Dividend yield
2.85%
Primary exchange
NASDAQ
About
Founded
1996
Website
Employees
99
